Sponsor of the Day:
Jerkmate
https://www.biospace.com/drug-development/jpm26-with-leqembi-launched-biogen-looks-to-expand-alzheimers-presence
JPM26: With Leqembi Launched, Biogen Looks To Expand Alzheimer’s Presence - BioSpace
Feb 24, 2026 - Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with Eli Lilly and its Kisunla...
jpm26leqembilaunchedbiogenlooks
https://www.protagonist-inc.com/jpm26-protagonist-has-a-400m-decision-to-make-its-a-no-brainer
Protagonist Speaks to BioSpace at #JPM26
Jan 30, 2026 - Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing...
protagonistspeaksbiospacejpm26
https://events.endpoints.news/jpm26
Endpoints at #JPM26 - January 12-13, 2026 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM.
12 13 2026san franciscoendpointsjpm26january
https://www.biospace.com/business/deep-dive-biospace-takes-on-jpm26-in-san-francisco
Deep Dive: BioSpace Takes On JPM26 in San Francisco - BioSpace
Mar 4, 2026 - The BioSpace team hit the ground running at the J.P. Morgan Healthcare Conference earlier this month to bring you the news from the streets of San Francisco.
deep divesan franciscobiospacetakesjpm26